Washington Health Institute | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pre-Exposure Prophylaxis Study of Lenacapavir in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People at Risk for HIV Infection	Pre-Exposure Prophylaxis of HIV Infection	Active, not recruiting	Phase 3	2026-10-06		NCT04925752
Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance	HIV-1-infection	Active, not recruiting	Phase 2 / Phase 3	2026-10-01		NCT04150068
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age	COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia	Active, not recruiting	Phase 3	2026-04-13		NCT07300839
Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV	HIV-1 Infection	Active, not recruiting	Phase 2	2026-02-04		NCT05052996
The DC Cohort Longitudinal HIV Status Neutral Study	AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease	Recruiting	Not stated	2026-02-02		NCT01206920
Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T	HIV	Enrolling by invitation	Not stated	2022-12-02		NCT05529342